US Vaccination Board recommends Biontech approval for 5-11 year olds

Approval of Biontech-Pfizer’s corona vaccine for children aged five to eleven in the United States is getting closer: The FDA’s vaccination committee recommended on Tuesday that the vaccine be granted emergency approval for this age group. The experts were of the opinion that the benefits of a vaccination clearly outweighed possible risks – and emphasized that the coronavirus is also dangerous for children.

Younger children would be “anything but spared Covid-19,” said FDA scientist Peter Marks. In this age group, 1.9 million corona infections, more than 8,300 hospital admissions – with treatment in the intensive care unit in a third of the cases – and around 100 deaths were registered.

source site